Evidence map›Paper›PMID 24326612›Full record

ArticleJournal of visualized experiments : JoVE2013

An orthotopic bladder cancer model for gene delivery studies.

Laura Kasman, Christina Voelkel-Johnson

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. A Murine Orthotopic Bladder Tumor Model and Tumor Detection System.Journal of visualized experiments : JoVE · 2017
    Article
  10. Polymer-enhanced delivery increases adenoviral gene expression in an orthotopic model of bladder cancer.Journal of controlled release : official journal of the Controlled Release Society · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Laura KasmanDepartment of Microbiology & Immunology, Medical University of South Carolina.
Christina Voelkel-Johnson
Medical University of South Carolina · US

Funding

Targeted Polymer-Adenovirus Hybrids for Ablation of Bladder Cancer DiseaseR21CA143505 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI REGE, KAUSHAL, VOELKEL-JOHNSON, CHRISTINA · 2010 to 2011
$353k
NCI NIH HHS R21 CA143505
6 · The paper itself

Abstract

Bladder cancer is the second most common cancer of the urogenital tract and novel therapeutic approaches that can reduce recurrence and progression are needed. The tumor microenvironment can significantly influence tumor development and therapy response. It is therefore often desirable to grow tumor cells in the organ from which they originated. This protocol describes an orthotopic model of bladder cancer, in which MB49 murine bladder carcinoma cells are instilled into the bladder via catheterization. Successful tumor cell implantation in this model requires disruption of the protective glycosaminoglycan layer, which can be accomplished by physical or chemical means. In our protocol the bladder is treated with trypsin prior to cell instillation. Catheterization of the bladder can also be used to deliver therapeutics once the tumors are established. This protocol describes the delivery of an adenoviral construct that expresses a luciferase reporter gene. While our protocol has been optimized for short-term studies and focuses on gene delivery, the methodology of mouse bladder catheterization has broad applications.

Indexed as

Gene Transfer TechniquesAdenoviridaeAnimalsFemaleGenetic TherapyGenetic VectorsLuciferasesLuminescent MeasurementsMaleMiceTransgenesUrinary Bladder NeoplasmsUrinary CatheterizationLuciferases

Identifiers

PMID24326612
PMCPMC4011168
OpenAlexW2167137621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.